Aucta Pharmaceuticals, Inc. (AUCTA, Latin: improved, enhanced) is a technology-based company focusing on the development and commercialization of Branded Specialty Products and Technology Platform-based Niche Generics.

Aucta is a pharmaceutical company creating enhanced products from proven molecules using the 505(b)(2) regulatory pathway.  Through innovation, Aucta is creating new therapeutics, including new dosage forms, new dosing regimens, and new indications.

Aucta has a clear therapeutic focus in CNS disorders, Ophthalmics, and Inhalation Therapy.  We are committed to being patient-centric by continuously bringing improved forms of proven molecules into the marketplace.

Aucta has operations in both New Jersey, the United States, and Shanghai, China.